Back

Targeting mitochondrial stress with SS31 reduces ascending aortic dilation and improves cardiac performance in a preclinical model of Marfan disease.

31 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Mitochondrial signalling and metabolic control in cardiovascular disease Mitochondria ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Rafael Almendra-Pegueros

Research Institute - Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
The role of CD38 in age-related vascular dysfunction: a sex-dependent factor
Doctor Y. Puspitasari (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Sting reestablishes mitochondrial homeostasis in heart failure
Ms T. Heryed (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Mitochondrial DNA activates the inflammasome in cardiac fibroblasts and promotes adverse cardiac remodeling
Doctor S. Omiya (Suita, JP)
Abstract Slides Video
Presentation thumbnail
ERR-gamma coupled with a membrane protein of Akkermansia muciniphila regulates cardiac mitochondrial dynamics and energy metabolism
Associate Professor Q. Su (Belfast, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Mitochondrial signalling and metabolic control in cardiovascular disease

The Event

Event poster

ESC Congress 2025

31 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Oral low-dose rapamycin treatment prevents aortic aneurysms in marfan mice
thumbnail
Congress Presentation
Exploration of cyclophilin A antibody anti-eCypA as a new approach in the treatment of marfan syndrome
thumbnail
Congress Presentation
Targeting MEK signalling with PD0325901 halts aortic dilatation and wall stiffening in a murine model of thoracic aortic aneurysm

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources